Efeito da Toxina Botulínica Tipo A na Espasticidade e Qualidade de Vida: um Caso Clínico de Síndrome de Leigh
DOI:
https://doi.org/10.25759/spmfr.131Keywords:
Botulinum Toxins Type A, Leigh Disease, Muscle Spasticity, Quality of LifeAbstract
The purpose of this case report is to highlight the role of botulinum toxin type A in the treatment of spasticity and its benefits improving quality of life, taking into account the clinical evolution of a patient with Leigh syndrome.
Leigh syndrome is a subacute necrotizing encephalomyelopathy, a progressive neurodegenerative disorder with onset usually before 12 months of age and with no specific treatment. Spasticity is one of the possible symptoms that can precipitate several complications.
This case report shows the effects of botulinum toxin type A in controlling severe focal spasticity during patient’s growth in an attempt to manage pain and minimize orthopedic deformities. Although there was no objective measure available, the clinical evolution and the information given by the patient and his family confirm an improvement in quality of life.
Downloads
Downloads
How to Cite
Issue
Section
License
Copyright statement
Authors must also submit a copyright statement (as seen below) on article submission.
To the Editor-in-chief of the SPMFR Journal:
The below signed author(s) hereby state that the article
________________________________________ (ref. MFR_________) is
an original unpublished work and all facts stated are a product of the author(s) investigation. This article does not violate any copyright laws or privacy statements. The author(s) also hereby confirm that there is no conflict of interest's issues in this article.
By submitting this article the author(s) agree that after publication all copyrights belong to the SPMFR Journal.
Signed by all authors
Date:
Names (capital letters):
Signatures:
The SPMFR Journal’s contents are follow a Creative Commons licence. After publication the authors can hand out the articles as long as the SPMFR Journal is credited.
